Published in Heart Disease Weekly, October 19th, 2003
Iconix CEO Jim Neal made the announcement concurrent with his speaking engagement at the 15th annual Life Sciences Partnering Meeting in San Francisco, sponsored by Burrill & Co.
Used in drug discovery, drug signatures are sets of biomarker genes associated with a specific compound, compound family, toxicology end-point, or efficacy readout. Each signature provides a prediction or indication of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.